Abstract
Influenza A viruses (IAVs) significantly impact animal and human health due to their zoonotic potential. A growing body of evidence indicates that the host's long noncoding RNAs (lncRNAs) play crucial roles in regulating host-virus interactions during IAV infection. However, numerous lncRNAs associated with IAV infection have not been well characterised. Here, in this study, we identify the LINC01197 as an antiviral host factor. LINC01197 was significantly upregulated after IAV infection, which is controlled by the NF-κB pathway. Functional analysis revealed that overexpression of LINC01197 inhibited IAV replication and virus production, while knockdown of LINC01197 facilitated IAV replication. Mechanistically, LINC01197 directly interacts with poly(A) binding protein cytoplasmic 1 (PABPC1), which in turn sequesters and restricts its functions. This work shows that LINC01197 acts as a protein decoy, suppressing IAV replication and playing a key role in controlling IAV replication.
What Problem Does This Paper Address?
Influenza A Virus (IAV) remains a significant global health threat due to its zoonotic potential and ability to cause pandemics. While much research has focused on how viral and host proteins interact, the role of the "dark matter" of the genome—long noncoding RNAs (lncRNAs)—is less understood.
lncRNAs are RNA molecules longer than 200 nucleotides that do not code for proteins but instead regulate cellular processes by acting as signals, guides, or scaffolds. The authors sought to identify specific host lncRNAs that are triggered by IAV infection and determine whether they help the virus or help the host fight back.
Methods
The study utilized a variety of molecular biology techniques to map the lifecycle and function of LINC01197:
- Expression Analysis: Used qRT-PCR and Western blotting to track LINC01197 and viral protein levels in various human cell lines (primarily A549 lung epithelial cells).
- Pathway Mapping: Employed luciferase reporter assays and Chromatin Immunoprecipitation (ChIP) to prove that the NF-κB pathway—a central regulator of inflammation—directly controls the transcription of LINC01197.
- Interactome Identification: To find out what LINC01197 actually does, the team used biotinylated RNA pull-down followed by Mass Spectrometry. This identified PABPC1 as a primary binding partner.
- Validation of Mechanism: Used RNA Immunoprecipitation (RIP) and Co-Immunoprecipitation (Co-IP) to demonstrate that LINC01197 physically competes with viral mRNA for PABPC1 binding and disrupts the interaction between PABPC1 and the viral NS1 protein.
Key Insights and Ideas
- The NF-κB Connection: LINC01197 is actively induced by the host's innate immune response. The researchers found that the NF-κB p65 subunit directly binds to the LINC01197 promoter during infection.
- The "Decoy" Strategy: Many lncRNAs work by regulating gene expression in the nucleus. However, LINC01197's primary antiviral activity occurs in the cytoplasm. It acts as a molecular sponge (decoy) for PABPC1.
- Sabotaging Viral Translation: IAV normally hijacks PABPC1 to facilitate the translation of its own mRNA. By sequestering PABPC1, LINC01197 effectively starves the virus of the machinery it needs to produce new viral proteins.
- Disrupting the NS1 Complex: The viral protein NS1 usually binds PABPC1 to enhance viral protein synthesis. LINC01197 physically interferes with this interaction, adding a second layer of defense.
Key Results
IAV infection triggered a significant, dose- and time-dependent increase in LINC01197 expression across multiple cell lines and viral strains. Subcellular localization analysis confirmed that while LINC01197 is present in the nucleus, it is significantly enriched in the cytoplasm during infection, where it can interact with PABPC1.
Functional analysis revealed that overexpressing LINC01197 significantly reduced IAV M1 protein levels and lowered viral titers. Conversely, knocking down LINC01197 using siRNA led to a significant increase in viral production. Mass spectrometry identified PABPC1 as the top-scoring protein interactor, and the inhibitory effect of LINC01197 on the virus could be partially reversed by adding recombinant PABPC1, proving that the lncRNA's effect is specifically mediated through this protein.
Limitations and Future Work
- In Vitro Focus: The study was conducted entirely in cell culture models. Future research is needed to determine if LINC01197 plays the same protective role in vivo (e.g., in mouse models).
- Nuclear Role Unexplored: While the authors focused on the cytoplasmic "decoy" function, they noted that LINC01197 is also present in the nucleus. Its potential role in nuclear gene regulation during infection remains a mystery.
- Breadth of Activity: It is currently unknown if LINC01197 acts as a decoy for other viruses that rely on PABPC1, or if its activity is specific to the unique way IAV utilizes the protein.
Summary updated